A combined treatment of L-carnitine and L-acetyl-carnitine was found to increase sperm motility, especially in patients with lower baseline levels, in a study in Fertility and Sterility (2004; 81:1578-84).
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.